Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised Dexmedetomidine vs Saline for Hemodynamic Response to Intubation
NCT07596004Active, not recruiting
- Sponsor
- Shaheed Mohtarma Benazir Bhutto Institute of Trauma
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine (2 arms), sponsored by Shaheed Mohtarma Benazir Bhutto Institute of Trauma. Primary endpoints: Mean Arterial Pressure and Heart Rate. Started Mar 2026; status: active, not recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT07596004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07596004.